Article
Clinical Neurology
Philip S. Insel, Christina B. Young, Paul S. Aisen, Keith A. Johnson, Reisa A. Sperling, Elizabeth C. Mormino, Michael C. Donohue
Summary: The rates of tau accumulation in cognitively unimpaired older adults are subtle and vary in magnitude and spatial patterns. The degree of regional accumulation also likely depends on the amyloid-beta-dependent accumulation. Therefore, it is important to evaluate the pattern and consistency of tau accumulation across multiple cohorts and its relationship with amyloid burden to design optimal tau endpoints for clinical trials.
Review
Pharmacology & Pharmacy
Mohammad Rafi Khezri, Keyvan Yousefi, Negin Mahboubi, Darya Hodaei, Morteza Ghasemnejad-Berenji
Summary: Alzheimer's disease (AD) is a common neurodegenerative disorder worldwide, and its association with diseases like diabetes has been well-studied. Metformin, a medication commonly used for type 2 diabetes, has shown potential disease-modifying effects on various aspects of AD pathophysiology.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Clinical Neurology
Ashvini Keshavan, Josef Pannee, Thomas K. Karikari, Juan Lantero Rodriguez, Nicholas J. Ashton, Jennifer M. Nicholas, David M. Cash, William Coath, Christopher A. Lane, Thomas D. Parker, Kirsty Lu, Sarah M. Buchanan, Sarah E. Keuss, Sarah-Naomi James, Heidi Murray-Smith, Andrew Wong, Anna Barnes, John C. Dickson, Amanda Heslegrave, Erik Portelius, Marcus Richards, Nick C. Fox, Henrik Zetterberg, Kaj Blennow, Jonathan M. Schott
Summary: The study compared three different blood-based techniques for identifying early stage Alzheimer's disease, with mass spectrometry plasma measures performing significantly better than other measures.
Article
Clinical Neurology
Ashvini Keshavan, Josef Pannee, Thomas K. Karikari, Juan Lantero Rodriguez, Nicholas J. Ashton, Jennifer M. Nicholas, David M. Cash, William Coath, Christopher A. Lane, Thomas D. Parker, Kirsty Lu, Sarah M. Buchanan, Sarah E. Keuss, Sarah-Naomi James, Heidi Murray-Smith, Andrew Wong, Anna Barnes, John C. Dickson, Amanda Heslegrave, Erik Portelius, Marcus Richards, Nick C. Fox, Henrik Zetterberg, Kaj Blennow, Jonathan M. Schott
Summary: The study compared three different blood-based techniques to detect amyloid PET positivity in dementia-free individuals, finding that mass spectrometry plasma measures performed significantly better than other measures, with higher sensitivity and specificity for detecting amyloid PET positivity.
Article
Nutrition & Dietetics
Simon W. So, Kendra M. Fleming, Joshua P. Nixon, Tammy A. Butterick
Summary: Obesity, a known risk factor for Alzheimer's disease, increases microglial activation and inflammation. In this study, we found that a high fat diet led to neuroinflammation and cognitive decline in mice. The activation of brain microglia in obesity exacerbated AD pathology and increased the accumulation of amyloid beta plaques. Our results showed that a high fat diet decreased locomotor activity and increased anxiety-like behavior and behavioral despair. It also led to memory deficits and increased microgliosis and Aβ deposition in a young adult AD mouse model.
Review
Cell Biology
Albin John, Kiran Ali, Harrison Marsh, P. Hemachandra Reddy
Summary: The COVID-19 pandemic has severely strained the medical system, with elderly individuals and those with comorbidities facing higher risks. Studying the impact of COVID-19 on AD patients provides insights into how the virus affects vulnerable populations through aging.
AGEING RESEARCH REVIEWS
(2021)
Article
Clinical Neurology
Shuntaro Natsume, Hajime Baba, Hitoshi Maeshima, Takao Saida, Naoto Yoshinari, Kentaro Shimizu, Toshihito Suzuki
Summary: Depression is a risk factor for Alzheimer's disease, and changes in A13 protein metabolism may contribute to the transition from depression to AD. This study found that elderly patients with depression had decreased A1342 levels at admission, but these levels recovered to healthy levels 1 year after remission.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Article
Clinical Neurology
Pratishtha Chatterjee, Steve Pedrini, Nicholas J. Ashton, Michelle Tegg, Kathryn Goozee, Abhay K. Singh, Thomas K. Karikari, Joel Simren, Eugeen Vanmechelen, Nicola J. Armstrong, Eugene Hone, Prita R. Asih, Kevin Taddei, Vincent Dore, Victor L. Villemagne, Hamid R. Sohrabi, Henrik Zetterberg, Colin L. Masters, Kaj Blennow, Ralph N. Martins
Summary: This study found that GFAP and p-tau have good diagnostic and longitudinal monitoring potential in preclinical Alzheimer's disease. Combining GFAP with other proteins can improve diagnostic accuracy.
ALZHEIMERS & DEMENTIA
(2022)
Review
Immunology
Ingrid H. C. H. M. Philippens, Jan A. M. Langermans
Summary: With the aging population, modern society is increasingly dealing with neurological diseases like Alzheimer's disease. Understanding the role of the immune system in the early pathology of Alzheimer's disease is crucial for developing protective treatments. Additionally, the lack of relevant translational animal models is hindering the development of new disease-modifying therapies.
Article
Clinical Neurology
Can Sheng, Kun Yang, Beiqi He, Wenying Du, Yanning Cai, Ying Han
Summary: This study found that the composition of gut microbiota is altered in preclinical AD, and the combination of plasma Aβ and gut microbiota can serve as a diagnostic tool for early AD screening.
ALZHEIMERS RESEARCH & THERAPY
(2022)
Review
Biochemistry & Molecular Biology
Anne-Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, Monique Vogel, Martin F. Bachmann
Summary: Alzheimer's disease is the most common form of dementia and is responsible for 60-70% of cases. The number of people with dementia is expected to triple by 2050 due to an aging population. Currently, there are only symptomatic treatments available, making it crucial to develop novel therapeutic strategies to prevent or delay the onset of Alzheimer's disease. This mini-review focuses on the understanding of Alzheimer's disease pathobiology and discusses current immunomodulating therapies targeting amyloid-beta protein.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
MiaoMiao Xu, Jun Guo, JiaCheng Gu, LinLin Zhang, ZiHao Liu, Lin Ding, HongLiang Fu, YuFei Ma, Sheng Liang, Hui Wang
Summary: A new Aβ tracer [F-18]DRKXH1 was synthesized and evaluated for its performance in diagnosing AD using various methods. The tracer showed promising results in detecting Aβ plaques in the brains of AD transgenic mice and AD patients, suggesting its potential for in vivo detection of the human brain.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Neurosciences
Akinori Futamura, Sotaro Hieda, Yukiko Mori, Kensaku Kasuga, Azusa Sugimoto, Hideyo Kasai, Takeshi Kuroda, Satoshi Yano, Mayumi Tsuji, Takeshi Ikeuchi, Kazuhiro Irie, Kenjiro Ono
Summary: The study compared toxic A beta conformers at different stages of AD, with toxic A beta(42) conformers positively correlated with p-tau in AD, and p-tau negatively correlated with cognitive function, indicating that toxic A beta conformers trigger tau accumulation leading to neuronal impairment in AD pathogenesis.
JOURNAL OF ALZHEIMERS DISEASE
(2021)
Review
Chemistry, Medicinal
Weimin Qiu, Hui Liu, Yijun Liu, Xin Lu, Lei Wang, Yanyu Hu, Feng Feng, Qi Li, Haopeng Sun
Summary: Alzheimer's disease (AD) is a difficult to treat progressive neurodegenerative disease characterized by the accumulation of amyloid beta (A beta) plaques in the brain. A beta interacts with various receptors on the plasma membrane and mediates signaling pathways that contribute to the development of AD. Despite ongoing research, there are currently no effective medications for AD. This review discusses the importance of A beta in the pathogenesis of AD, recent progress in targeting A beta-related receptors and compounds, and the challenges and opportunities in developing effective therapies for AD.
MEDICINAL RESEARCH REVIEWS
(2023)
Review
Geriatrics & Gerontology
Marleigh Hefner, Vineet Baliga, Kailinn Amphay, Daniela Ramos, Vijay Hegde
Summary: Recent studies have highlighted the strong connections between cardiometabolic disorders and neurodegenerative disorders, with amyloid beta (A beta) playing a crucial role as a link between them. A beta, originating from both peripheral tissues and the brain itself, regulates neuronal function but its accumulation in the brain may contribute to neurodegenerative pathologies.
FRONTIERS IN AGING NEUROSCIENCE
(2021)
Article
Neuroimaging
Catherine L. Gallagher, Sterling C. Johnson, Barbara B. Bendlin, Moo K. Chung, James E. Holden, Terrence R. Oakes, Benjamin R. Brooks, Richard A. Konopacki, Selami Dogan, James H. Abbs, Guofan Xu, Robert J. Nickles, Robert W. Pyzalski, Onofre T. DeJesus, W. Douglas Brown
BRAIN IMAGING AND BEHAVIOR
(2011)
Article
Clinical Neurology
Kimberly D. M. Farbota, Aparna Sodhi, Barbara B. Bendlin, Donald G. McLaren, Guofan Xu, Howard A. Rowley, Sterling C. Johnson
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
(2012)
Article
Clinical Neurology
Catherine L. Gallagher, Terrence R. Oakes, Sterling C. Johnson, Moo K. Chung, James E. Holden, Barbara B. Bendlin, Donald G. McLaren, Guofan Xu, Robert J. Nickles, Robert Pyzalski, Onofre DeJesus, W. Douglas Brown
MOVEMENT DISORDERS
(2011)
Article
Neurosciences
Chris Hinrichs, Vikas Singh, Guofan Xu, Sterling C. Johnson
Article
Neurosciences
Donald G. McLaren, Michele L. Ries, Guofan Xu, Sterling C. Johnson
Article
Neurosciences
Won Hwa Kim, Vikas Singh, Moo K. Chung, Chris Hinrichs, Deepti Pachauri, Ozioma C. Okonkwo, Sterling C. Johnson
Article
Behavioral Sciences
Michele L. Ries, Donald G. McLaren, Barbara B. Bendlin, GuofanXu, Howard A. Rowley, Rasmus Birn, Erik K. Kastman, Mark A. Sager, Sanjay Asthana, Sterling C. Johnson
Article
Endocrinology & Metabolism
Auriel A. Willette, Christopher L. Coe, Ricki J. Colman, Barbara B. Bendlin, Erik K. Kastman, Aaron S. Field, Andrew L. Alexander, David B. Allison, Richard H. Weindruch, Sterling C. Johnson
PSYCHONEUROENDOCRINOLOGY
(2012)
Article
Geriatrics & Gerontology
Aadhavi Sridharan, Auriel A. Willette, Barbara B. Bendlin, Andrew L. Alexander, Christopher L. Coe, Mary L. Voytko, Ricki J. Colman, Joseph W. Kemnitz, Richard H. Weindruch, Sterling C. Johnson
FRONTIERS IN AGING NEUROSCIENCE
(2012)
Article
Clinical Neurology
P. A. Rowley, M. J. Paukner, L. B. Eisenmenger, A. S. Field, R. J. Davidson, S. C. Johnson, S. Asthana, N. A. Chin, V. Prabhakaran, B. B. Bendlin, B. R. Postle, H. H. Goldsmith, C. M. Carlsson, M. A. Brooks, N. H. Kalin, L. E. Williams, H. A. Rowley
Summary: This study investigated 16,400 brain MRIs and found that incidental findings are common, ranging from trivial to life-threatening. Formal neuroradiologist interpretation yielded more reliable results compared to spontaneous detection by nonradiology scanning staff.
AMERICAN JOURNAL OF NEURORADIOLOGY
(2023)
Article
Neuroimaging
Ruben Smith, Olof Strandberg, Antoine Leuzy, Tobey J. Betthauser, Sterling C. Johnson, Joana B. Pereira, Oskar Hansson
Summary: The study reveals a sex difference in off-target binding in the meninges/skull using three different tau PET tracers. Women exhibit higher meningeal off-target binding compared to men across all tracers, and there is also a gender difference in baseline skull/meningeal SUVR values. Additionally, off-target binding in the skull/meninges decreases with age for [F-18]flortaucipir and [F-18]RO948.
NEUROIMAGE-CLINICAL
(2021)
Article
Neuroimaging
Samantha L. Allison, Rebecca L. Koscik, Robert P. Cary, Erin M. Jonaitis, Howard A. Rowley, Nathaniel A. Chin, Henrik Zetterberg, Kaj Blennow, Cynthia M. Carlsson, Sanjay Asthana, Barbara B. Bendlin, Sterling C. Johnson
NEUROIMAGE-CLINICAL
(2019)
Article
Psychology, Developmental
Megan L. Zuelsdorff, Rebecca L. Koscik, Ozioma C. Okonkwo, Paul E. Peppard, Bruce P. Hermann, Mark A. Sager, Sterling C. Johnson, Corinne D. Engelman
AGING NEUROPSYCHOLOGY AND COGNITION
(2019)
Article
Clinical Neurology
Andrew P. Merluzzi, Nicholas M. Vogt, Derek Norton, Erin Jonaitis, Lindsay R. Clark, Cynthia M. Carlsson, Sterling C. Johnson, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS
(2019)